H79TI086770

Providers Clinical Support System- Medications for Opioid Use Disorders - Project Abstract Summary:

PCSS-MOUD opioid related overdoses continue at unprecedented rates, adversely impacting individuals, families, and communities nationwide. Substantive efforts have been made by federal and state agencies, including the Providers Clinical Support System (PCSS)-MAT.

While PCSS-MAT has made significant progress over the last decade in providing innovative training, mentoring, and implementation support for prescribers and allied health professionals in the use of evidence-based harm reduction, prevention, treatment, and recovery of opioid use disorders (OUD), more is needed.

In response, the American Academy of Addiction Psychiatry (AAAP) proposes in this application to continue working with the large coalition of national professional organizations of PCSS partner organizations and the PCSS Steering Committee while significantly broadening representation. Our partners and Steering Committee include experts in addiction psychiatry and medicine, specialty care physicians, nurses, physician assistants, pharmacists, and dentists. We propose to build upon this work to include social workers, counselors, and the recovery community.

Further, given that the most recent increases in overdoses are situated in Black and Indigenous communities, we will work to better meet the needs of historically minoritized and under-resourced communities. Building upon current and prior work led by AAAP and a committed consortium of partners representing the spectrum of interdisciplinary health professions, the overarching goal of this application is to increase the availability and accessibility of FDA-approved medications for OUD (MOUD).

This PCSS consortium proposes to continue to expand and diversify activities to meet the following objectives:

1) Continued education (including a focus on stigma reduction);
2) Training (including new DEA required trainings);
3) Knowledge-building (including the basics of OUD, poly-substance use, and co-occurring mental and physical disorders);
4) Clinical mentorship; and
5) Implementation support (to address systemic factors that can facilitate or impede treatment delivery, expansion, and sustainability).

This work will be augmented by the Addiction Technology Transfer Center (ATTC) and the Peer Recovery COE to better integrate recovery into PCSS activities and broadening representation of other SAMHSA Technical Assistance (TA) Centers to better serve rural and historically minoritized communities, including Rural Opioid Technical Assistance (ROTA) and the African American Behavioral Health Center of Excellence (COE).

PCSS activities will also focus on expanding multidisciplinary team-based care, including inviting new partners from allied health professional fields (e.g., National Association of Social Workers, National Association of Alcohol and Drug Addiction Counselors, African American Behavioral Health COE). Finally, AAAP will provide leadership on diversity, equity, and inclusion (DEI) and awareness of culturally responsive training and resources by including their DEI Director and Community Engagement Director to the PCSS Steering Committee.

The overdose crisis, exacerbated by COVID-19, has compelled us to re-evaluate our approach on how best to overcome stigma, be more patient-centered, and provide care in culturally responsive ways. PCSS-MOUD is structured to respond rapidly to emerging issues (e.g., contaminants in the drug supply like xylazine), as well as maximizing foundational training and support resources.

The goal of PCSS-MOUD is not to duplicate efforts but to streamline and enhance activities across the country by coordinating and collaborating with other SAMHSA-funded TA programs to more effectively meet the needs of people with OUD, especially those experiencing health disparities. This can be accomplished by a concerted and focused effort to fill gaps in the availability of prevention, treatment, recovery, and harm reduction services and where we can build and expand.

American Academy Of Addiction Psychiatry

SAMHSA WAS GIVEN THE AUTHORITY TO ADDRESS PRIORITY SUBSTANCE ABUSE TREATMENT, PREVENTION AND MENTAL HEALTH NEEDS OF REGIONAL AND NATIONAL SIGNIFICANCE THROUGH ASSISTANCE (GRANTS AND COOPERATIVE AGREEMENTS) TO STATES, POLITICAL SUBDIVISIONS OF STATES, INDIAN TRIBES AND TRIBAL ORGANIZATIONS, AND OTHER PUBLIC OR NONPROFIT PRIVATE ENTITIES. UNDER THESE SECTIONS, CSAT, CMHS AND CSAP SEEK TO EXPAND THE AVAILABILITY OF EFFECTIVE SUBSTANCE ABUSE TREATMENT AND RECOVERY SERVICES AVAILABLE TO AMERICANS TO IMPROVE THE LIVES OF THOSE AFFECTED BY ALCOHOL AND DRUG ADDITIONS, AND TO REDUCE THE IMPACT OF ALCOHOL AND DRUG ABUSE ON INDIVIDUALS, FAMILIES, COMMUNITIES AND SOCIETIES AND TO ADDRESS PRIORITY MENTAL HEALTH NEEDS OF REGIONAL AND NATIONAL SIGNIFICANCE AND ASSIST CHILDREN IN DEALING WITH VIOLENCE AND TRAUMATIC EVENTS THROUGH BY FUNDING GRANT AND COOPERATIVE AGREEMENT PROJECTS. GRANTS AND COOPERATIVE AGREEMENTS MAY BE FOR (1) KNOWLEDGE AND DEVELOPMENT AND APPLICATION PROJECTS FOR TREATMENT AND REHABILITATION AND THE CONDUCT OR SUPPORT OF EVALUATIONS OF SUCH PROJECTS, (2) TRAINING AND TECHNICAL ASSISTANCE, (3) TARGETED CAPACITY RESPONSE PROGRAMS (4) SYSTEMS CHANGE GRANTS INCLUDING STATEWIDE FAMILY NETWORK GRANTS AND CLIENT-ORIENTED AND CONSUMER RUN SELF-HELP ACTIVITIES AND (5) PROGRAMS TO FOSTER HEALTH AND DEVELOPMENT OF CHILDREN, (6) COORDINATION AND INTEGRATION OF PRIMARY CARE SERVICES INTO PUBLICLY-FUNDED COMMUNITY MENTAL HEALTH CENTERS AND OTHER COMMUNITY-BASED BEHAVIORAL HEALTH SETTINGS

93.243 - Substance Abuse and Mental Health Services Projects of Regional and National Significance

Division of Grants Management [HHS - SAMHSA]

Rhode Island United States

State-Wide

Provider’s Clinical Support System – Medications for Opioid Use Disorder (TI-23-014)

Amendment Since initial award the total obligations have increased 167% from $1,500,000 to $4,000,000.